In recent years diisopropylfluorophosphonate (DFP) has established itself as a useful drug in such conditions as intestinal and vesical atonia, glaucoma and myasthenia gravis. With the consolidation of its place in therapy the desirability of more precise knowledge of the fate of this compound in the human organism became obvious. In the present study the absorption, the distribution in the blood and the excretion of DFP have been studied after intramuscular injection of the radioactive labelled substance (DFP32) into three patients suffering from myasthenia gravis (two cases) and arteriosclerosis cerebri, respectively, and into two normal persons. There are no theoretical reasons why the metabolic fate of DFP should be different from normal in the patients studied. Indeed, no essential differences were observed between results obtained from the three patients and those from the normal persons. Therefore, all results to be described should be considered as applicable to the metabolism of DFP in the normal human organism.
Rijswijk, Netherlands) (Submitted for publication May 12, 1953; accepted October 28, 1953) In recent years diisopropylfluorophosphonate (DFP) has established itself as a useful drug in such conditions as intestinal and vesical atonia, glaucoma and myasthenia gravis. With the consolidation of its place in therapy the desirability of more precise knowledge of the fate of this compound in the human organism became obvious. In the present study the absorption, the distribution in the blood and the excretion of DFP have been studied after intramuscular injection of the radioactive labelled substance (DFP32) into three patients suffering from myasthenia gravis (two cases) and arteriosclerosis cerebri, respectively, and into two normal persons. There are no theoretical reasons why the metabolic fate of DFP should be different from normal in the patients studied. Indeed, no essential differences were observed between results obtained from the three patients and those from the normal persons. Therefore, all results to be described should be considered as applicable to the metabolism of DFP in the normal human organism.
In the course of this work it became obvious that the phosphorus of DFP32 was irreversibly bound to the proteins of blood plasma and red cells and that DFP was exclusively broken down to diisopropylphosphate, a substance which is not further metabolised nor taken up into any normal metabolic pool. Such properties suggested that DFP32 might prove to be a useful tool in the study of the turnover of blood plasma proteins and red cells. Preliminary results of the use of DFP32 in the determination of the life span of red cells and the half life of a plasma protein will be included in this study.
EXPERIMENTAL METHODS
Synthesis of DFP". DFP'2 was prepared from H3P204 purchased from the Atomic Energy Research Establishment at Harwell by a method to be described elsewhere. It was injected intramuscularly as a solute in 1 to 2 ml. of peanut oil.
Radioactivity measurements. In the absorption experiments, samples of 0.1 ml. blood obtained from the fingertip were pipetted into flat counting dishes, which were provided with a snugly fitting piece of filter paper in the bottom. After drying, the samples were counted with a conventional Geiger Muiller tube. All other radioactivity measurements were carried out with a G.M. liquid counter (M<, of 20th Century Electronics). All measurements were related to standards consisting of diiso-)ropylphosphate obtained by alkaline hydrolysis of a sample of DFP3" of known quantity and radioactivity.
Treatmentt of blood, urine, and feces for radioactivity imeasurements. Ten milliliters of blood obtained by venepuncture were collected in sodium citrate (final concentration 0.76 per cent). Red cells were separated from the plasma and washed thrice in normal saline. Counting was carried out on the hemolysate in distilled water. Samples, diluted if necessary, from 24-hour portions of urine were counted directly in the liquid counter. Feces were collected in aliquots over a period of 24 hours and mixed. Samples of 2 Gm. were suspended in a small volume of water and hydrolyzed during 15 minutes at 1000 C. in molar NaOH.
Cholinesterase activity. Cholinesterase activity was measured manometrically at 370 C. according to Ammon (1) using acetylcholine as a substrate.
Paper chromatography. Paper chromatography was carried out on samples of 40 /A. of urine using an ascending method with butanol-acetic acid-water mixtures as solvent. The development period lasted 16 hours at a temperature of 230 C.
Organic phosphates were made visible on the paper by a method which was essentially that of Hanes and Isherwood (2) with slight modifications. Radioactivity on the paper was assessed by exposing x-ray films in direct contact with the chromatogram in the dark room for 72 hours.
RESULTS
The first series of experiments were performed on three young women. Two cof these were 
Resorption of DFP
Blood samples from the fingertip from A and B were examined for radioactivity at 15-minute intervals. Figure 1 shows the course of the radioactivity of the whole blood in counts per minute during an observation period of 130 minutes. There are two main differences between the curves obtained from A and B. Firstly, the maximal activity is reached after 30 minutes in Case A and only after 90 minutes in Case B. Secondly, the level of radioactivity is much higher in the latter case in spite of the fact that only one-eighth of the amount of radioactivity had been injected. These differences are readily explained as the result of the pretreatment with OMPA to which A had been subjected. This treatment has certainly resulted in blocking of the majority of the sites present on proteins of blood plasma and cells which are capable of reacting with DFP. These sites are readily accessible in Case B where they react with DFP to form the irreversible protein-DFP-reaction products well known from cholinesterase inhibition studies. The unbound DFP is assumed to be rapidly removed by the liver, the kidney, and other organs and the difference in level of curves A and B is thus explained on account of differences in bound DFP content of the blood. If the supposition is right that the protein-DFP linkages are irreversible, radioactivity will disappear at the rate of replacement of those proteins by newly formed molecules.
Binding of p32 to elements of the blood For this experiment blood samples from A, B. D, and E were drawn at intervals. After separation of red cells and plasma the amount of DFP in micrograms that had reacted with plasma and cells, respectively, was calculated from the observed radioactivity.
Results are expressed in Figures 2 and 3 . It is apparent that, in spite of the larger amount of DFP injected into A, the plasma and red cells harbour considerably less radioactivity than those of B, D, and E, as would be expected from the results presented in the previous passage.
Red cell and plasma cholinesterase activity was measured in the blood of B (Figure 4) Excretion of DFP32 Radioactivity was measured in the urine of A, B, and C and also in the feces of A and B. In all cases, 60 to 70 per cent of the P32 injected as DFP appeared in the urine during the first 10 days ( Figure 5 ). One-third was found in the urine in the first 24 hours. The amount of p32 excreted in the urine of A was slightly greater in the first few days and slightly less after the first three to four days compared with B and C. This difference may be due to the OMPA treatment in case A, resulting in a modification of the ratio protein-bound/free p32 During the observation period less than 5 per cent of the injected radioactivity was recovered in the feces (Figure 6 ).
Paper chromatography of urint
The results so far reported provide only information on the distribution of the P32 incorporated in the injected DFP molecules. They convey nothing concerning the chemical alterations of the DFP molecule between its injection and its excretion. Therefore, the urine was further analysed by paper chromatography to elucidate the chemical character of the radioactive compounds it contained. Portions of urine of B and C collected during the first days after the injection were analysed. Portions Figure 7 a chromatogram is presented of five samples of urine of C with additions as indicated. Number 6 is a control in water.
Unmixed urine (No. 1 in Figure 7) shows two large unidentified spots. Comparison with numbers 2, 5, and 6 suggests that the upper part of the lower spot contains probably inorganic phosphate. MIP is located immediately under the upper spot (2. 4, and 6) whereas DIP travels in the front (2, 3, and 6). The original urine (1) cannot be expected to give readily demonstrable spots resulting from DFP or its break-down products because the technique used is not sensitive enough to give a colour with the traces of phosphate32 excreted in 40 M1. of urine (see Figure 5) .
If, however, an x-ray film is exposed to the same chromatogram, an autoradiogram is obtained. A drawing of this radiogram is presented in Figure  7b . (Figure 8 ). DFP is rapidly absorbed from the intramuscular depot. The presence of radioactive material in the blood can be demonstrated a few minutes after the injection. At the dosage used, maximal radioactivity in the blood is observed after 90 minutes, after which a slow decline occurs, indicating that removal now is predominant over resorption. Free DFP disappears rapidly from the circulation into such organs as kidney, liver, and lung which have been shown to contain radioactivity in similar experiments on rabbits described by Jandorf and 1IcNamarra (3) . A large fraction is probably hydrolyzed in the tissues to DIP and excreted into the urine and to a far less extent into the feces.
The hydrolysis may be spontaneous but is more likely to be essentially enzymatic. The enzyme system responsible is probably the fluorophosphatase, present in liver and kidney, as described by Mazur (4) .
A certain amount of DFP32 reacts With the proteins of red cells, blood plasma and tissues. It is implied in the scheme of Figure 8 that this reaction is irreversible and that the reaction products are stable. This assumption is based on many studies reported in the literature, where it has been shown that a number of animal proteins, such as chymotrypsin, trypsin, cholinesterases, aliesterases etc. react with DFP. In all these instances the reaction was irreversible and the reaction product stable. It seems likely that this protein-DFP interaction bears the same character as the reaction between DFP and chymotrypsin described by Jansen, Nutting, Jang, and Balls (5, 6) . It was found that in this reaction DFP lost its fluorine atom whereas the diisopropylphosphate moiety became firmly attached to the protein. As a result of the irreversible character of this linkage further metabolism of the protein bound P32 containing moiety is henceforth dependent on the break-down of the protein molecule to which it is attached. When this breakdown occurs. again DIP is the product formed.
H7C30
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DFP + Fto 10 days after the injection of DFP32 the red cell bound radioactivity remains constant. After that period radioactivity falls at a steady rate which may be measured and used for calculations of life span. The reason for this initial constancy has not been studied. Similarly irreversible combination of injected DFP32 with blood plasma can be used for the calculation of plasma protein turnover (Figure 2 ). In this case, the curves depicting the elimination of the labelled plasma protein fraction were exponential reflecting random destruction. A mean red cell life span of 116 and 129 days, respectively, was found in two subjects.
5. Injected DFP is excreted in the urine as diisopropylphosphate (60 to 70 per cent in the first ten days); less than 5 per cent of the p32 injected as DFP is recovered in the feces during that period.
6. In one person DFP receptors were blocked by treatment with OMPA (octamethylpyrophosphoramide) prior to the injection of DFP22. In this case less radioactivity was bound to plasma and red cells and maximal radioactivity in the blood was reached as soon as 30 minutes after the injection of DFP. Excretion was slightly accelerated. These data are understandable on account of the relative decrease of firmly bound and increase of free DFP32 as a result of the OMPA pretreatment. The free DFP is more readily removed from the blood than the bound fraction.
7. It is suggested that labelling by means of DFP32 may also be used for the evaluation of red cell and plasma volume.
